United States · FDA National Drug Code directory
Arformoterol Tartrate Inhalation
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-151_3bd6ebed-0405-445a-8613-ae20b2e70703
- Product NDC
- 70436-151
- Form
- SOLUTION
- Composition / generic term
- Arformoterol Tartrate Inhalation
- Labeler
- Slate Run Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210622
- Source listing expiry
- 20261231
Source-listed ingredients
- ARFORMOTEROL TARTRATE — 15 ug/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (70436-151-57) / 1 VIAL in 1 POUCH (70436-151-19) / 2 mL in 1 VIAL · 70436-151-57
- 15 POUCH in 1 CARTON (70436-151-58) / 4 VIAL in 1 POUCH (70436-151-20) / 2 mL in 1 VIAL · 70436-151-58
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →